Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vistagen Therapeutics (VTGN) Preferred Dividend Payments (2016 - 2021)

Vistagen Therapeutics (VTGN) has disclosed Preferred Dividend Payments for 7 consecutive years, with $208000.0 as the latest value for Q4 2021.

  • Quarterly Preferred Dividend Payments fell 41.18% to $208000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $208000.0 through Sep 2022, down 85.55% year-over-year, with the annual reading at $945100.0 for FY2022, 31.79% down from the prior year.
  • Preferred Dividend Payments hit $208000.0 in Q4 2021 for Vistagen Therapeutics, down from $375000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $375000.0 in Q3 2021 to a low of $208000.0 in Q4 2021.
  • Historically, Preferred Dividend Payments has averaged $305206.2 across 5 years, with a median of $308150.0 in 2019.
  • Biggest five-year swings in Preferred Dividend Payments: tumbled 54.19% in 2017 and later increased 11.01% in 2020.
  • Year by year, Preferred Dividend Payments stood at $263000.0 in 2017, then rose by 10.61% to $290900.0 in 2018, then rose by 10.62% to $321800.0 in 2019, then rose by 9.88% to $353600.0 in 2020, then crashed by 41.18% to $208000.0 in 2021.
  • Business Quant data shows Preferred Dividend Payments for VTGN at $208000.0 in Q4 2021, $375000.0 in Q3 2021, and $362000.0 in Q2 2021.